Prevalence of occult HBV infection in haemodialysis patients with chronic HCV

Table 1 Demographic and clinical characteristics of patients

		HCV-RNAPositive(n = 22)	HCV-RNANegative(n = 28)	Total(n = 50)
Average age (yr)		47.2 ± 17	39.6 ± 15.6	42.9 ± 16.5
(age range)		(18 - 24)	(13-76)	(13 - 84)
Sex	Male	13 (59.1%)	17 (60.7%)	30 (60%)
	Female	9 (40.9%)	11 (39.3%)	20 (40%)
Average		4.9 ± 2.3	4.6 ± 2.1	4.8 ± 2.2
Haemodialysis
period (yrs)
(haemodialysis range)		(1 - 9)	(1-8)	(1-9)
ALT (IU/mL)		52.9 ± 52.8	29.3 ± 20.9	39.7 ± 39.7
		(4 - 186)	(2-88)	(2 - 186)
Insulated anti-HBs		7	14	21
Seropositivity		(31.8)	(50%)	(42%)
Insulated anti-HBc		3	1	4
IgG seropositivity		(13.6%)	(3.5%)	(8%)
Anti-HBs and anti-HBc IgG		10	6	16
Seropositivity		(45.4%)	(21.4%)	(32%)
Anti-HBs and anti-HBc IgG		2	7	9
Seronegativity		(9.1%)	(25%)	(18%)
HBV-DNA (PCR)		0	0	0
Positivity		(0%)	(0%)	(0%)